Gt(ROSA)26Sortm2(CMV-Bmi1,EGFP)Nki
Targeted Allele Detail
|
Symbol: |
Gt(ROSA)26Sortm2(CMV-Bmi1,EGFP)Nki |
Name: |
gene trap ROSA 26, Philippe Soriano; targeted mutation 2, The Netherlands Cancer Institute |
MGI ID: |
MGI:4398914 |
Synonyms: |
Bmi1Lox66/Lox71, Bmi-CTI |
Gene: |
Gt(ROSA)26Sor Location: Chr6:113044389-113054205 bp, - strand Genetic Position: Chr6, 52.73 cM
|
Alliance: |
Gt(ROSA)26Sortm2(CMV-Bmi1,EGFP)Nki page
|
|
Germline Transmission: |
Earliest citation of germline transmission:
J:187257
|
Parent Cell Line: |
Not Specified (ES Cell)
|
Strain of Origin: |
129S4/SvJae
|
|
Allele Type: |
|
Targeted (Conditional ready, No functional change) |
Mutation: |
|
Insertion
|
|
|
Mutation details: The targeting construct contains a CMV promoter followed by a LoxP66 site, a cDNA encoding an antisense mouse Bmi1, an IRES, an eGFP cassette and a LoxP71 followed by a PGK promoter neo cassette. Cre expression enables the inversion of the antisense Bmi1.
(J:187257)
|
|
Schematic of the Gt(ROSA)26Sortm2(CMV-Bmi1,EGFP)Nki allele |
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Gt(ROSA)26Sor Mutation: |
942 strains or lines available
|
|
Original: |
J:187257 Westerman BA, et al., GFAP-Cre-mediated transgenic activation of Bmi1 results in pituitary tumors. PLoS One. 2012;7(5):e35943 |
All: |
1 reference(s) |
|